by Gérard Emilien, Cécile Durlach, Kenneth Lloyd Minaker, Bengt Winblad, Serge Gauthier, Jean-Marie Maloteaux.
Basel
Birkhäuser Basel : Imprint : Birkhäuser
2004
(XXIV, 288 pages)
Introduction --;Part I: Biological correlates of Alzheimer disease: Chapter 1: Alzheimer disease. Chapter 2: Neurological dysfunctions in Alzheimer disease. Chapter 3: Pharmacology of Alzheimer disease. Chapter 4: Molecular genetics of Alzheimer disease. Chapter 5: Promises of animal models of Alzheimer disease --;Part II:Neuropsychology of Alzheimer disease: Chapter 6: What is memory? Chapter 7: Mild Cognitive Impairment. Chapter 8: Cognitive impairment in Alzheimer disease. Chapter 9: Behavioral and psychological impairments. Chapter 10: Assessment of memory. Chapter 11: Functional abilities and behavioral symptom assessments --;Part III:Treatment of Alzheimer disease: Chapter 12: Pharmacological treatments of cognitive deficits. Chapter 13: Pharmacological treatment of neuropsychiatric symptoms. Chapter 14: Psychological support and cognitive rehabilitation. Chapter 15: Discussion and conclusion.
Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level.
Alzheimer's disease -- Chemotherapy.
Alzheimer's disease.
RC523
.
B944
2004
by Gérard Emilien, Cécile Durlach, Kenneth Lloyd Minaker, Bengt Winblad, Serge Gauthier, Jean-Marie Maloteaux.